
|Articles|January 1, 2003
Glaucoma drugs may pose risk to ocular surface
Author(s)Julia Talsma
Orlando-Ophthalmologists should be aware of the risks to the ocular surface associated with long-term use of glaucoma medications, according to Robert J. Noecker, MD, MBA, who also spoke at the Cornea Health symposium during the American Academy of Ophthalmology annual meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
2
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
3
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
4
From detection to decision-making: Navigating disease progression and treatment in geographic atrophy
5
























